Dr. Mohammed Murtaza

An internationally recognized leader in structural heart disease, Dr. Généreux has been a practicing interventional cardiologist for more than 15 years. He is the director of the structural heart program at Morristown Medical Center, has served as the primary or co-investigator on more than 20 clinical trials, and has published more than 350 articles in peer-reviewed journals. He is currently the principal investigator of the EARLY TAVR trial and the PROGRESS trial, two major studies in the field of aortic valve disease. A celebrated clinical researcher since the beginning of his career, he was awarded the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and has been named a Highly Cited Researcher by the Clarivate™ Web of Science™ Group for the last four years. Dr. Généreux is also involved in multiple early-stage companies in the field of interventional cardiology and heart failure. He received his medical degree from the Université de Montréal, Montréal, Québec, Canada, his cardiology and interventional cardiology degrees from Université de Sherbrooke and Sacré-Coeur Hospital, Montreal, Canada, and performed his advanced interventional cardiology and structural heart fellowship at Columbia University and Cardiovascular Research Foundation, in New York city. Dr. Genereux is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Coronary Heart Disease, Aortic Valve Replacement, and Percutaneous Coronary Intervention (PCI).

"Philosophy of care | I perform very complex cardiac and aortic reconstructive procedures. My philosophy regarding my patients is to complete these operations with the utmost skill, perfection and result as possible. Just as importantly, I spend time with my patients and their families to explain in great detail their condition and how we are going to treat it. This includes all the potential options available. My primary goal is to allow my patients some choice but, more importantly, to make sure they completely understand their disease process. My focus for many years has been a ""disease management process"" that fosters a long-term commitment to my patients revolving around the specifics of aortic and valvular heart disease. | Why I entered medicine | Initially, I wanted to be a political scientist; however, a number of life experiences changed that. My grandfather had Lou Gehrig’s disease and lived with us when I was growing up. This daily experience had a profound effect during formative years in high school. Interestingly, our next-door neighbor was a general/vascular surgeon, and I came to know him quite well. He was my initial mentor in this field. I initially studied engineering but was fascinated with cardiac physiology and this translated into medicine and cardiac surgery specifically. However, the passion and commitment to treat patients and their suffering was first embedded in my psyche secondary to witnessing, in all domains, my grandfather's demise from Lou Gehrig’s disease. | Community involvement | President, The Thoracic Surgery Foundation, impacting the global community by delivering quality thoracic care to lower- and middle-income countries across the world. | Personal interests | I enjoy traveling the world, Philadelphia professional sports, golfing and coaching baseball.". Dr. Bavaria is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Bicuspid Aortic Valve, Thoracic Aortic Aneurysm, Aortic Dissection, Aortic Valve Replacement, and Heart Valve Repair.

Dr. Gennaro Giustino is an Interventional Cardiologist with coronary, endovascular and structural heart disease training. He completed his Internal Medicine Residency, Cardiovascular Medicine and Interventional Cardiology Fellowship at The Mount Sinai Hospital - Icahn School of Medicine in New York, during which he served as Chief Fellow under Dr Valentin Fuster. Then, he went to complete an advanced fellowship in Structural Heart Disease and Mechanical Cardiocirculatory Support at Henry Ford Heart and Vascular Institute under Dr William O'Neill. He has published more than 300 peer-reviewed manuscripts and abstracts in cardiovascular medicine. In addition, he has participated in the inception, design and conduction of multiple randomized controlled trials and registries resulting in publications in the most prestigious journals including The New England Journal of Medicine, The Lancet, the Journal of the American College of Cardiology (JACC) and Circulation. He is also routinely invited as a faculty at international conferences and as a peer-reviewer for leading scientific journals. He is board-certified in Internal Medicine, Cardiovascular Medicine, Interventional Cardiology, Echocardiography and Cardiac Computed Tomography. He also speaks multiple languages, including Spanish, Italian, and French. Dr. Giustino is rated as an Elite provider by MediFind in Transcatheter Aortic Valve Replacement (TAVR). His top areas of expertise are Heart Attack, Coronary Heart Disease, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).